2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid

C54H74N10O18S3 — CID 160536014

IUPAC2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid
SMILESCC(O)[C@H]1NC(=O)[C@H](C)NC(=O)[C@H](C[C@@](C)(O)CO)NC(=O)[C@H]2CC(=O)[C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](CSc3[nH]c4ccc(NC(=O)CCCCC(=O)CCCC(=O)CN5C(=O)CSCSCC(=O)N5CC(=O)O)cc4c3C2)NC1=O
InChIInChI=1S/C54H74N10O18S3/c1-27-41(70)15-30-14-36-35-16-31(57-42(71)11-6-5-8-32(67)9-7-10-33(68)20-63-43(72)23-83-26-84-24-44(73)64(63)21-45(74)75)12-13-37(35)60-52(36)85-22-39(53(81)62-19-34(69)17-40(62)50(79)55-27)59-51(80)46(29(3)66)61-47(76)28(2)56-49(78)38(58-48(30)77)18-54(4,82)25-65/h12-13,16,27-30,34,38-40,46,60,65-66,69,82H,5-11,14-15,17-26H2,1-4H3,(H,55,79)(H,56,78)(H,57,71)(H,58,77)(H,59,80)(H,61,76)(H,74,75)/t27-,28-,29?,30+,34+,38-,39+,40-,46+,54+/m0/s1
InChIKeyRHMVAYJZXDYJQB-WUJAVIBZSA-N
MW1247.44 g/mol
LogP-1.75
Rot. Bonds18

About 2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid

2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid (PubChem CID 160536014) has the molecular formula C54H74N10O18S3 and a molecular weight of 1247.44 g/mol. Its IUPAC name is 2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid.

Molecular Properties

Compound Name2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid
PubChem CID160536014
Molecular FormulaC54H74N10O18S3
Molecular Weight1247.44 g/mol
Exact Mass1246.43
IUPAC Name2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid
SMILESCC(O)[C@H]1NC(=O)[C@H](C)NC(=O)[C@H](C[C@@](C)(O)CO)NC(=O)[C@H]2CC(=O)[C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](CSc3[nH]c4ccc(NC(=O)CCCCC(=O)CCCC(=O)CN5C(=O)CSCSCC(=O)N5CC(=O)O)cc4c3C2)NC1=O
InChIInChI=1S/C54H74N10O18S3/c1-27-41(70)15-30-14-36-35-16-31(57-42(71)11-6-5-8-32(67)9-7-10-33(68)20-63-43(72)23-83-26-84-24-44(73)64(63)21-45(74)75)12-13-37(35)60-52(36)85-22-39(53(81)62-19-34(69)17-40(62)50(79)55-27)59-51(80)46(29(3)66)61-47(76)28(2)56-49(78)38(58-48(30)77)18-54(4,82)25-65/h12-13,16,27-30,34,38-40,46,60,65-66,69,82H,5-11,14-15,17-26H2,1-4H3,(H,55,79)(H,56,78)(H,57,71)(H,58,77)(H,59,80)(H,61,76)(H,74,75)/t27-,28-,29?,30+,34+,38-,39+,40-,46+,54+/m0/s1
InChIKeyRHMVAYJZXDYJQB-WUJAVIBZSA-N
XLogP-1.75
TPSA420.75 Ų
H-Bond Donors12
H-Bond Acceptors20
Rotatable Bonds18
Heavy Atoms85
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001247.44
LogP ≤ 5-1.75
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid?
The IUPAC name of 2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid (CID 160536014) is 2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid.
What is the SMILES notation for 2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid?
The canonical SMILES for 2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid is CC(O)[C@H]1NC(=O)[C@H](C)NC(=O)[C@H](C[C@@](C)(O)CO)NC(=O)[C@H]2CC(=O)[C@H](C)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](CSc3[nH]c4ccc(NC(=O)CCCCC(=O)CCCC(=O)CN5C(=O)CSCSCC(=O)N5CC(=O)O)cc4c3C2)NC1=O.
What is the InChIKey of 2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid?
The InChIKey is RHMVAYJZXDYJQB-WUJAVIBZSA-N. The full InChI is InChI=1S/C54H74N10O18S3/c1-27-41(70)15-30-14-36-35-16-31(57-42(71)11-6-5-8-32(67)9-7-10-33(68)20-63-43(72)23-83-26-84-24-44(73)64(63)21-45(74)75)12-13-37(35)60-52(36)85-22-39(53(81)62-19-34(69)17-40(62)50(79)55-27)59-51(80)46(29(3)66)61-47(76)28(2)56-49(78)38(58-48(30)77)18-54(4,82)25-65/h12-13,16,27-30,34,38-40,46,60,65-66,69,82H,5-11,14-15,17-26H2,1-4H3,(H,55,79)(H,56,78)(H,57,71)(H,58,77)(H,59,80)(H,61,76)(H,74,75)/t27-,28-,29?,30+,34+,38-,39+,40-,46+,54+/m0/s1.
What are the key properties of 2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid?
2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid has a molecular weight of 1247.44 g/mol, XLogP of -1.75, 18 rotatable bonds, 12 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[7-[11-[[(1R,14S,18R,20S,23S,28S,31S,34R)-28-[(2R)-2,3-dihydroxy-2-methylpropyl]-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-15,21,24,26,29,32,35-heptaoxo-12-thia-10,16,22,27,30,33,36-heptazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4(9),5,7-tetraen-6-yl]amino]-2,6,11-trioxoundecyl]-5,8-dioxo-1,3,6,7-dithiadiazonan-6-yl]acetic acid is sourced from PubChem (CID 160536014), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).